ADVR Advanced Viral Research Corp. is engaged in the production and marketing, and promotion and sale, of a pharmaceutical drug, Reticulose. In addition to Reticulose, which has been used exclusively with its original formulation, the Company is developing a new formulation, which, to date, has been designated only by its generic name, Product R. The term "Product R" refers to the formulation, as well as the prior formulation of the pharmaceutical drug known as Reticulose. Product R may be employed in the treatment of certain viral and autoimmune diseases, such as human immunodeficiency virus (HIV AIDS)..